{
  "actions": [
    {
      "acted_at": "2017-03-30", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-03-30", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Ways and Means.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1840-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "D000616", 
      "district": "4", 
      "name": "DesJarlais, Scott", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-07-14", 
      "state": "TN", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "E000179", 
      "district": "16", 
      "name": "Engel, Eliot L.", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-06-07", 
      "state": "NY", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "E000215", 
      "district": "18", 
      "name": "Eshoo, Anna G.", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-05-23", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "G000410", 
      "district": "29", 
      "name": "Green, Gene", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-30", 
      "state": "TX", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "L000567", 
      "district": "7", 
      "name": "Lance, Leonard", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-09-05", 
      "state": "NJ", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "R000515", 
      "district": "1", 
      "name": "Rush, Bobby L.", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-30", 
      "state": "IL", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S000364", 
      "district": "15", 
      "name": "Shimkus, John", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-30", 
      "state": "IL", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "T000460", 
      "district": "5", 
      "name": "Thompson, Mike", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-30", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "W000799", 
      "district": "1", 
      "name": "Walz, Timothy J.", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-30", 
      "state": "MN", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-03-30", 
  "number": "1840", 
  "official_title": "To amend the Internal Revenue Code of 1986 to allow a credit against tax for clinical testing expenses for qualified infectious disease drugs and rapid diagnostic tests.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017", 
  "sponsor": {
    "bioguide_id": "P000594", 
    "district": "3", 
    "name": "Paulsen, Erik", 
    "state": "MN", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-03-30", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Health technology, devices, supplies", 
    "Income tax credits", 
    "Infectious and parasitic diseases", 
    "Medical tests and diagnostic methods", 
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2017-03-30T04:00:00Z", 
    "text": "Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017\n\nThis bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Internal Revenue Code of 1986 to allow a credit against tax for clinical testing expenses for qualified infectious disease drugs and rapid diagnostic tests.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2017-09-06T07:16:01Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr1840.xml"
}